DALLA COSTA, GLORIA
 Distribuzione geografica
Continente #
EU - Europa 2.043
NA - Nord America 1.357
AS - Asia 1.223
SA - Sud America 237
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 26
OC - Oceania 2
Totale 4.949
Nazione #
RU - Federazione Russa 1.301
US - Stati Uniti d'America 1.278
SG - Singapore 459
CN - Cina 385
SE - Svezia 222
IT - Italia 197
BR - Brasile 192
HK - Hong Kong 134
VN - Vietnam 108
DE - Germania 70
FR - Francia 68
GB - Regno Unito 51
CA - Canada 44
FI - Finlandia 34
BD - Bangladesh 28
IE - Irlanda 25
IN - India 25
PL - Polonia 22
AT - Austria 21
MX - Messico 15
ES - Italia 14
IQ - Iraq 14
JP - Giappone 14
AR - Argentina 13
ZA - Sudafrica 12
ID - Indonesia 9
TR - Turchia 9
EC - Ecuador 8
CO - Colombia 6
CL - Cile 5
JM - Giamaica 5
MA - Marocco 5
NL - Olanda 5
PY - Paraguay 5
IR - Iran 4
MY - Malesia 4
PK - Pakistan 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
HN - Honduras 3
NI - Nicaragua 3
NP - Nepal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
KG - Kirghizistan 2
PE - Perù 2
PH - Filippine 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
ML - Mali 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
UA - Ucraina 1
VG - Isole Vergini Britanniche 1
Totale 4.888
Città #
Ashburn 221
Singapore 220
Moscow 184
San Jose 138
Hong Kong 132
Dallas 83
Council Bluffs 67
Shanghai 67
Beijing 58
Hefei 53
Milan 51
Lauterbourg 47
Lawrence 46
Princeton 46
New York 43
Los Angeles 37
Santa Clara 37
Hanoi 30
Ho Chi Minh City 27
Dublin 25
Phoenix 25
São Paulo 25
Helsinki 24
Munich 23
Warsaw 18
Boardman 16
Rome 15
Manchester 14
Montreal 14
Tokyo 14
Nuremberg 13
Orem 13
Vienna 13
Atlanta 12
Boston 12
Houston 12
Miano 12
Frankfurt am Main 11
Poplar 11
Brooklyn 10
Chicago 10
London 10
Chennai 9
Stockholm 9
Johannesburg 8
Mexico City 8
Rio de Janeiro 8
Denver 7
Guangzhou 7
Haiphong 7
Cesano Boscone 6
Da Nang 6
Hải Dương 6
San Francisco 6
Turku 6
Ankara 5
Bologna 5
Curitiba 5
Pisa 5
Seattle 5
Tianjin 5
Toronto 5
Baghdad 4
Brasília 4
Indpls 4
Mumbai 4
Secaucus 4
Belo Horizonte 3
Bengaluru 3
Bergamo 3
Biên Hòa 3
Calgary 3
Dammam 3
Ferrara 3
Guayaquil 3
Jacksonville 3
Lappeenranta 3
Miami 3
Naples 3
Nova Iguaçu 3
Salvador 3
Savannah 3
Sulaymaniyah 3
Wroclaw 3
Agadir 2
Annapolis 2
Assago 2
Bishkek 2
Bogotá 2
Brampton 2
Buffalo 2
Campinas 2
Caracas 2
Cincinnati 2
Columbus 2
Durban 2
Florence 2
Greenville 2
Guarapuava 2
Guarulhos 2
Totale 2.170
Nome #
Using smartphones and wearable devices to monitor behavioral changes during COVID-19 567
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 181
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 131
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 123
Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study 123
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 110
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 109
Repetitive Transcranial Magnetic Stimulation With H-Coil in Alzheimer's Disease: A Double-Blind, Placebo-Controlled Pilot Study 106
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 104
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data 102
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 102
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 101
Fifteen years of wireless sensors for balance assessment in neurological disorders 100
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 99
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 97
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 97
The Danger of Walking with Socks: Evidence from Kinematic Analysis in People with Progressive Multiple Sclerosis 96
High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis 94
Dysregulation of MS risk genes and pathways at distinct stages of disease 92
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 90
Digital epidemiology confirms a latitude gradient of MS in France 88
From neuroimaging to clinical setting: What have we learned from migraine pain? 84
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 82
Early clinical and mri predictors of long-term disability in pediatric multiple sclerosis patients 79
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 79
Walking-related digital mobility outcomes as clinical trial endpoint measures: Protocol for a scoping review 76
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 74
Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis 74
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease 74
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes 73
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 73
Parry Romberg Syndrome associated with chronic facial pain. 72
LETTER RE: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study 72
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 67
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 66
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 66
Individual risk of multiple sclerosis in clinically isolated syndromes: a multicenter prospective Italian study 64
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 64
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. 64
Opinion & special articles: professionalism in neurology. Maintaining patient rapport in a world of EMR. 64
Vitamin D levels and risk of developing multiple sclerosis 64
Comparison of the 2017 and 2010 Revisions of the McDonald Criteria in Patients with CIS Suggestive of MS: A Multicentre MAGNIMS Study 63
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome 63
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation 62
Comparison of the 2017 and 2010 revisions of the mcdonald criteria in patients with cis suggestive of ms: a multicentre magnims study 60
Individual risk of multiple sclerosis in clinically isolated syndromes: a multicenter prospective Italian study 59
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective 58
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study 58
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 56
Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy” 56
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. 54
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection. 49
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy 46
Neurofilament light biomarkers in MS: Effects of extended natalizumab dosing 44
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis 21
Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres 19
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis 18
Assessing disease progression and treatment response in progressive multiple sclerosis 16
null 1
null 1
null 1
null 1
Totale 4.949
Categoria #
all - tutte 27.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202264 0 0 0 30 2 3 5 4 5 0 0 15
2022/2023331 115 84 27 0 0 38 23 30 13 0 1 0
2023/2024615 0 2 29 18 19 14 5 18 1 5 6 498
2024/2025734 76 25 9 16 32 47 115 67 121 53 64 109
2025/20262.572 206 163 114 399 202 108 211 219 699 132 47 72
2026/2027588 103 148 126 211 0 0 0 0 0 0 0 0
Totale 4.949